Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

 What do you think?

Home >  What do you think? > What is supervision?


Supervision — what do you think?

The Royal Pharmaceutical Society's Council is to hold a special meeting in November to consider its policy on the supervision of medicines sales and dispensing in pharmacies. The meaning of supervision has been explored by the Society's head of ethics, Helen Darracott. Does it require the physical presence of a pharmacist for all transactions or should they only have to be accountable for what goes on under systems they have approved?

Read what she told the Council in October here.

What do you think? E-mail your views to editoronline@pharmj.org.uk. They are posted below.

PJ Online reserves the right to abridge submissions, to edit them for clarity and style and to restrict contributors to a single posting only.


Replies

29 October 2001
Douglas Hancox (I fully support a relaxation in the pharmacy supervision requirements. However...)

2 November 2001
Charles Butler (There is no doubt that changes are required... However...)

Douglas Hancox
New Zealand

I fully support a relaxation in the pharmacy supervision requirements. However, before that occurs I would suggest there is need for the Society to conclude its discussions on ensuring the competence of pharmacy support staff upon which Council consulted members in August 2000.

As part of that competence issue I firmly believe that pharmacy technicians should be registered by an appropriate body (preferably the Society) and should be subject to a code of ethics and a continuing professional development requirement.

Given such registration and regulation of pharmacy technicians it will be possible to relax the current, strict, definition and interpretation of supervision so as to allow pharmacists to provide a wider range of pharmaceutical services within pharmacy premises and to be absent from the pharmacy for brief periods of time provided they can be immediately contacted by pharmacy staff when the need arises.

These changes will enable a pharmacy to establish new services in which, for example, the pharmacist is on the premises but fully engaged in the delivery of pharmaceutical care in a separate consultation area or the pharmacist is off the premises providing a professional service to, for example, a GP practice or rest home.

As and when a relaxation in the supervision requirements occurs operating systems and procedures will need to be drawn up in respect of

  • professional/clinical checking of all prescriptions by a pharmacist (preferably as the first step in the dispensing process)
  • final accuracy checking by a pharmacist or accredited checking technician (preferably one who has not been involved in the assembly, preparation or labelling of the dispensed items)
  • handing out of dispensed items, together with relevant advice, by a pharmacist or pharmacy technician
  • the sale of medicines by trained pharmacy staff — with guidelines for referral to a pharmacist or pharmacy technician when appropriate
  • a means of contacting a pharmacist who is away from the pharmacy

The Society's Code of Ethics rightly requires accountability and this must surely operate at three levels. The proprietor/superintendent community pharmacist, and the hospital chief pharmacist/senior pharmacy manager, must be accountable for the establishment and maintenance of the pharmacy's operating systems and procedures. The pharmacist-in-charge at any one time must be accountable for the effective operation of the established systems at that time while individual pharmacists, and pharmacy technicians must remain accountable for their own actions.

Charles Butler
Reading

There is no doubt that changes are required in order to modernise community pharmacy and I support some relaxation in supervision requirements. However, no change must be allowed to compromise any aspect of current practice which is of great value to consumers.

As guardians of public safety in medicines-related issues and by virtue of public accessibility to a conveniently located open-access service, community pharmacy provides what the consumer wants and needs: immediate access to a network of pharmacies staffed by knowledgeable health professionals, supported by trained and competent staff.

The question is how can pharmacy meet Government objectives, while still satisfying public demand and undertake professional re-engineering at the same time without creating additional problems along the way? The answer lies in a hybrid.

More pharmacists are needed. If convenience of location and access is to be preserved then the formation of group practices of two or more neighbouring pharmacies will only be a practical solution in a very limited number of situations. For most of the country there is little scope for reduction in pharmacy numbers without at the same time compromising access. Similarly, e-pharmacy, walk-in centres or NHS Direct will not reduce the need for maintaining the network of pharmacies; instead they will serve to increase demands on primary care.

Pharmacists need to let go of the technical aspects of dispensing and medicines sales, allowing trained, and possibly regulated and registered staff, to work under protocols. Training and certification of medicines counter assistants is now well established but more rigour is needed in the system. Methods should be introduced to continually refresh and update the knowledge and competencies of these important front-line staff and dispensing assistants.

Standard operating systems and protocols must be introduced to allow competent staff to work in the absence of a pharmacist, provided the pharmacist can be consulted immediately problems arise and can quickly be present to advise patients when required. Web-cam links between the pharmacy and a pharmacist working remotely, perhaps along the road at a GP practice, sound attractive but it is impossible to pick up accurately on body language with this type of technology. Pharmacist interventions in the future could be limited to situations only where there is significant concern, for example, over appropriateness of treatment, safety or concordance issues. Under these circumstances, there is no substitute for face-to-face interviews with patients.

I am not yet ready to accept a situation where a pharmacist can be absent from the pharmacy premises for more than a few minutes at a time while the work of that pharmacy continues. I am happy, however, to contemplate a situation in which the pharmacist is, for example, conducting some type of clinic within the same building but away from the immediate area where dispensing and medicines sales are occurring. Providing competent staff are working to set procedures then patient safety and access should remain uncompromised.

Back to top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal